Matthew Katcher

Matthew Katcher has a diverse work experience spanning various roles in the pharmaceutical and academia sectors. Matthew currently works at Terray Therapeutics as an Associate Director and Molecular Design Lead, where they lead an interdisciplinary team in utilizing data to accelerate drug discovery. Prior to that, they were a Senior Scientist at AbbVie, where they led data analysis and informatics for the DNA-Encoded Libraries (DEL) platform and also worked as a Medicinal Chemist in lead optimization and hit-to-lead spaces. Matthew has also worked as a Research Assistant Professor at Northwestern University, studying medicinal chemistry and investigating new organic chemistry methodology. Earlier in their career, they held postdoctoral positions at MIT, where they researched the synthesis of ladder polyether natural products and amino acids using photochemistry, and they also worked as a Graduate Student at Princeton University, specializing in palladium-catalyzed reactions. Additionally, they have experience as a Medicinal Chemist at Merck and a Summer Intern at Genzyme. Matthew Katcher has made contributions to patent applications, publications, and has been involved in committees focused on instrument maintenance and decreasing downtime.

Matthew Katcher's education history consists of a Ph.D. in Chemistry from Princeton University, which they completed from 2008 to 2013. In 2012, they also spent a brief period as a Visiting Student in Computational Chemistry at the University of Gothenburg. Prior to their Ph.D., they earned an A.B. in Chemistry from Harvard University, graduating between 2001 and 2005. It is unclear whether Matthew pursued any additional degrees or fields of study at Harvard University after completing their undergraduate education.